Scribe Therapeutics Statistics
NASDAQ: SCTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
17.57+1.24 (+7.59%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 17.57 0.00%
Scribe Therapeutics by the numbers
Scribe Therapeutics has a market capitalization of $332.6 million based on 18.93M shares outstanding. With trailing EPS of $-3.84, Scribe Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 32.0% below its 50-day average and 31.6% below its 200-day average.
Average daily trading volume is 356.27K shares, or about $6.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SCTX valuation vs. peer median
| Metric | SCTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $332.63M | $336.56M | -1% |
| Avg. volume | 356.27K | 1.81M | -80% |
Peer median across 8 companies: SRZN, CABA, OCGN, XFOR, AGEN, ARTV, LXEO, CCCC.
Valuation
- Market cap
- $332.63M
- EPS (TTM)
- $-3.84
- Shares outstanding
- 18.93M
Price and trading
- Previous close
- 16.33
- Open
- 15.94
- Day range
- 15.75 – 18.16
- 52-week range
- 13.50 – 39.60
- Beta
- —
- Volume
- 400.70K
- Average volume
- 356.27K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 11, 2026
Additional statistics
- Market Cap
- 332.63M
- Forward Pe
- -4.86
- Eps
- -3.84
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 39.60
- Week52 Low
- 13.50
- Avg Volume
- 356.27K
- Shares Outstanding
- 18.93M
- Ma50
- 25.82
- Ma200
- 25.69
- Earnings Date
- Nov 11, 2026
- Pct From52w High
- -55.63%
- Pct From52w Low
- 30.15%